APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs Targeting SLC Transporters

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drugs Targeting SLC Transporters Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchDrugs Targeting SLC Transporters Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs Targeting SLC Transporters Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drugs Targeting SLC Transporters Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs Targeting SLC Transporters Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs Targeting SLC Transporters Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Drugs Targeting SLC Transporters market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drugs Targeting SLC Transporters is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs Targeting SLC Transporters is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs Targeting SLC Transporters is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs Targeting SLC Transporters is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs Targeting SLC Transporters include Zhengda Tianqing, Janssen Pharmaceuticals, Sandoz, Johnson & Johnson, Merck, Kelun Pharmaceutical, Bristol-Myers Squibb, AstraZeneca and Starpharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drugs Targeting SLC Transporters market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs Targeting SLC Transporters and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs Targeting SLC Transporters sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drugs Targeting SLC Transporters market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs Targeting SLC Transporters Segment by Company

Zhengda Tianqing

Janssen Pharmaceuticals

Sandoz

Johnson & Johnson

Merck

Kelun Pharmaceutical

Bristol-Myers Squibb

AstraZeneca

Starpharma

Orifarm

Jnana Therapeutics

Hengrui

Hansoh Pharmaceuticals

Boehringer Ingelheim

Drugs Targeting SLC Transporters Segment by Type

SGLT-2 Inhibitors

Antidepressants

Diuretics

Drugs Targeting SLC Transporters Segment by Application

Hospital

Clinic

Drugs Targeting SLC Transporters Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs Targeting SLC Transporters market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs Targeting SLC Transporters and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs Targeting SLC Transporters.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drugs Targeting SLC Transporters market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs Targeting SLC Transporters manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drugs Targeting SLC Transporters in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drugs Targeting SLC Transporters in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drugs Targeting SLC Transporters Industry Trends Table 2. Drugs Targeting SLC Transporters Industry Drivers Table 3. Drugs Targeting SLC Transporters Industry Opportunities and Challenges Table 4. Drugs Targeting SLC Transporters Industry Restraints Table 5. Global Drugs Targeting SLC Transporters Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drugs Targeting SLC Transporters Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drugs Targeting SLC Transporters Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Drugs Targeting SLC Transporters Sales Market Share by Manufacturers Table 9. Global Drugs Targeting SLC Transporters Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Drugs Targeting SLC Transporters Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drugs Targeting SLC Transporters Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drugs Targeting SLC Transporters Manufacturers, Product Type & Application Table 13. Global Drugs Targeting SLC Transporters Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drugs Targeting SLC Transporters by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of SGLT-2 Inhibitors Table 17. Major Manufacturers of Antidepressants Table 18. Major Manufacturers of Diuretics Table 19. Global Drugs Targeting SLC Transporters Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Drugs Targeting SLC Transporters Sales by Type (2021-2026) & (k units) Table 21. Global Drugs Targeting SLC Transporters Sales by Type (2027-2032) & (k units) Table 22. Global Drugs Targeting SLC Transporters Sales Market Share by Type (2021-2026) Table 23. Global Drugs Targeting SLC Transporters Sales Market Share by Type (2027-2032) Table 24. Global Drugs Targeting SLC Transporters Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Drugs Targeting SLC Transporters Revenue by Type (2021-2026) & (k units) Table 26. Global Drugs Targeting SLC Transporters Revenue by Type (2027-2032) & (k units) Table 27. Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2021-2026) Table 28. Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Global Drugs Targeting SLC Transporters Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Drugs Targeting SLC Transporters Sales by Application (2021-2026) & (k units) Table 33. Global Drugs Targeting SLC Transporters Sales by Application (2027-2032) & (k units) Table 34. Global Drugs Targeting SLC Transporters Sales Market Share by Application (2021-2026) Table 35. Global Drugs Targeting SLC Transporters Sales Market Share by Application (2027-2032) Table 36. Global Drugs Targeting SLC Transporters Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Drugs Targeting SLC Transporters Revenue by Application (2021-2026) & (k units) Table 38. Global Drugs Targeting SLC Transporters Revenue by Application (2027-2032) & (k units) Table 39. Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2021-2026) Table 40. Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2027-2032) Table 41. Global Drugs Targeting SLC Transporters Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Drugs Targeting SLC Transporters Sales by Region (2021-2026) & (k units) Table 43. Global Drugs Targeting SLC Transporters Sales Market Share by Region (2021-2026) Table 44. Global Drugs Targeting SLC Transporters Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Drugs Targeting SLC Transporters Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 48. North America Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 49. Europe Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 51. Europe Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Drugs Targeting SLC Transporters Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Drugs Targeting SLC Transporters Sales by Country (2027-2032) & (k units) Table 58. Global Drugs Targeting SLC Transporters Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Drugs Targeting SLC Transporters Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Drugs Targeting SLC Transporters Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Drugs Targeting SLC Transporters Revenue Market Share by Region (2021-2026) Table 62. Global Drugs Targeting SLC Transporters Revenue Market Share by Region (2027-2032) Table 63. Zhengda Tianqing Company Information Table 64. Zhengda Tianqing Business Overview Table 65. Zhengda Tianqing Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zhengda Tianqing Drugs Targeting SLC Transporters Product Portfolio Table 67. Zhengda Tianqing Recent Development Table 68. Janssen Pharmaceuticals Company Information Table 69. Janssen Pharmaceuticals Business Overview Table 70. Janssen Pharmaceuticals Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Janssen Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio Table 72. Janssen Pharmaceuticals Recent Development Table 73. Sandoz Company Information Table 74. Sandoz Business Overview Table 75. Sandoz Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sandoz Drugs Targeting SLC Transporters Product Portfolio Table 77. Sandoz Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Drugs Targeting SLC Transporters Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck Drugs Targeting SLC Transporters Product Portfolio Table 87. Merck Recent Development Table 88. Kelun Pharmaceutical Company Information Table 89. Kelun Pharmaceutical Business Overview Table 90. Kelun Pharmaceutical Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Kelun Pharmaceutical Drugs Targeting SLC Transporters Product Portfolio Table 92. Kelun Pharmaceutical Recent Development Table 93. Bristol-Myers Squibb Company Information Table 94. Bristol-Myers Squibb Business Overview Table 95. Bristol-Myers Squibb Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Bristol-Myers Squibb Drugs Targeting SLC Transporters Product Portfolio Table 97. Bristol-Myers Squibb Recent Development Table 98. AstraZeneca Company Information Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. AstraZeneca Drugs Targeting SLC Transporters Product Portfolio Table 102. AstraZeneca Recent Development Table 103. Starpharma Company Information Table 104. Starpharma Business Overview Table 105. Starpharma Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Starpharma Drugs Targeting SLC Transporters Product Portfolio Table 107. Starpharma Recent Development Table 108. Orifarm Company Information Table 109. Orifarm Business Overview Table 110. Orifarm Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Orifarm Drugs Targeting SLC Transporters Product Portfolio Table 112. Orifarm Recent Development Table 113. Jnana Therapeutics Company Information Table 114. Jnana Therapeutics Business Overview Table 115. Jnana Therapeutics Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Jnana Therapeutics Drugs Targeting SLC Transporters Product Portfolio Table 117. Jnana Therapeutics Recent Development Table 118. Hengrui Company Information Table 119. Hengrui Business Overview Table 120. Hengrui Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hengrui Drugs Targeting SLC Transporters Product Portfolio Table 122. Hengrui Recent Development Table 123. Hansoh Pharmaceuticals Company Information Table 124. Hansoh Pharmaceuticals Business Overview Table 125. Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio Table 127. Hansoh Pharmaceuticals Recent Development Table 128. Boehringer Ingelheim Company Information Table 129. Boehringer Ingelheim Business Overview Table 130. Boehringer Ingelheim Drugs Targeting SLC Transporters Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Boehringer Ingelheim Drugs Targeting SLC Transporters Product Portfolio Table 132. Boehringer Ingelheim Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Drugs Targeting SLC Transporters Distributors List Table 136. Drugs Targeting SLC Transporters Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Drugs Targeting SLC Transporters Product Image Figure 2. Global Drugs Targeting SLC Transporters Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs Targeting SLC Transporters Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs Targeting SLC Transporters Sales (2021-2032) & (k units) Figure 5. Global Drugs Targeting SLC Transporters Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drugs Targeting SLC Transporters Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. SGLT-2 Inhibitors Image Figure 9. Antidepressants Image Figure 10. Diuretics Image Figure 11. Global Drugs Targeting SLC Transporters Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Drugs Targeting SLC Transporters Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Drugs Targeting SLC Transporters Sales Market Share by Type (2021-2032) Figure 14. Global Drugs Targeting SLC Transporters Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Drugs Targeting SLC Transporters Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Drugs Targeting SLC Transporters Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Drugs Targeting SLC Transporters Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Drugs Targeting SLC Transporters Sales Market Share by Application (2021-2032) Figure 22. Global Drugs Targeting SLC Transporters Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Drugs Targeting SLC Transporters Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2021-2032) Figure 25. North America Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 27. U.S. Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 32. Germany Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 39. China Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Drugs Targeting SLC Transporters Sales Market Share by Country (2021-2032) Figure 47. Brazil Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Drugs Targeting SLC Transporters Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Drugs Targeting SLC Transporters Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Drugs Targeting SLC Transporters Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Drugs Targeting SLC Transporters Revenue (2021-2032) & (US$ Million) Figure 58. North America Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Drugs Targeting SLC Transporters Revenue (2021-2032) & (US$ Million) Figure 60. Europe Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Drugs Targeting SLC Transporters Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Drugs Targeting SLC Transporters Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Drugs Targeting SLC Transporters Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Drugs Targeting SLC Transporters Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • SGLT-2 Inhibitors
  • Antidepressants
  • Diuretics
Applications
  • Hospital
  • Clinic
Companies covered
  • Zhengda Tianqing
  • Janssen Pharmaceuticals
  • Sandoz
  • Johnson & Johnson
  • Merck
  • Kelun Pharmaceutical
  • Bristol-Myers Squibb
  • AstraZeneca
  • Starpharma
  • Orifarm
  • Jnana Therapeutics
  • Hengrui
  • Hansoh Pharmaceuticals
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drugs Targeting SLC Transporters Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drugs Targeting SLC Transporters Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drugs Targeting SLC Transporters Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drugs Targeting SLC Transporters Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drugs Targeting SLC Transporters Market Dynamics
  1. 2.1 Drugs Targeting SLC Transporters Industry Trends
  2. 2.2 Drugs Targeting SLC Transporters Industry Drivers
  3. 2.3 Drugs Targeting SLC Transporters Industry Opportunities and Challenges
  4. 2.4 Drugs Targeting SLC Transporters Industry Restraints
3 Drugs Targeting SLC Transporters Market by Manufacturers
  1. 3.1 Global Drugs Targeting SLC Transporters Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drugs Targeting SLC Transporters Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drugs Targeting SLC Transporters Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drugs Targeting SLC Transporters Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs Targeting SLC Transporters Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drugs Targeting SLC Transporters Manufacturers, Product Type & Application
  7. 3.7 Global Drugs Targeting SLC Transporters Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs Targeting SLC Transporters Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs Targeting SLC Transporters Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs Targeting SLC Transporters Tier 1, Tier 2, and Tier 3
4 Drugs Targeting SLC Transporters Market by Type
  1. 4.1 Drugs Targeting SLC Transporters Type Introduction
  2. 4.1.1 SGLT-2 Inhibitors
  3. 4.1.2 Antidepressants
  4. 4.1.3 Diuretics
  5. 4.2 Global Drugs Targeting SLC Transporters Sales by Type
  6. 4.2.1 Global Drugs Targeting SLC Transporters Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drugs Targeting SLC Transporters Sales by Type (2021-2032)
  8. 4.2.3 Global Drugs Targeting SLC Transporters Sales Market Share by Type (2021-2032)
  9. 4.3 Global Drugs Targeting SLC Transporters Revenue by Type
  10. 4.3.1 Global Drugs Targeting SLC Transporters Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Drugs Targeting SLC Transporters Revenue by Type (2021-2032)
  12. 4.3.3 Global Drugs Targeting SLC Transporters Revenue Market Share by Type (2021-2032)
5 Drugs Targeting SLC Transporters Market by Application
  1. 5.1 Drugs Targeting SLC Transporters Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Drugs Targeting SLC Transporters Sales by Application
  5. 5.2.1 Global Drugs Targeting SLC Transporters Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Drugs Targeting SLC Transporters Sales by Application (2021-2032)
  7. 5.2.3 Global Drugs Targeting SLC Transporters Sales Market Share by Application (2021-2032)
  8. 5.3 Global Drugs Targeting SLC Transporters Revenue by Application
  9. 5.3.1 Global Drugs Targeting SLC Transporters Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Drugs Targeting SLC Transporters Revenue by Application (2021-2032)
  11. 5.3.3 Global Drugs Targeting SLC Transporters Revenue Market Share by Application (2021-2032)
6 Global Drugs Targeting SLC Transporters Sales by Region
  1. 6.1 Global Drugs Targeting SLC Transporters Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs Targeting SLC Transporters Sales by Region (2021-2032)
  3. 6.2.1 Global Drugs Targeting SLC Transporters Sales by Region (2021-2026)
  4. 6.2.2 Global Drugs Targeting SLC Transporters Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drugs Targeting SLC Transporters Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drugs Targeting SLC Transporters Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drugs Targeting SLC Transporters Revenue by Region
  1. 7.1 Global Drugs Targeting SLC Transporters Revenue by Region
  2. 7.1.1 Global Drugs Targeting SLC Transporters Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drugs Targeting SLC Transporters Revenue by Region (2021-2026)
  4. 7.1.3 Global Drugs Targeting SLC Transporters Revenue by Region (2027-2032)
  5. 7.1.4 Global Drugs Targeting SLC Transporters Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drugs Targeting SLC Transporters Revenue (2021-2032)
  8. 7.2.2 North America Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drugs Targeting SLC Transporters Revenue (2021-2032)
  11. 7.3.2 Europe Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drugs Targeting SLC Transporters Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drugs Targeting SLC Transporters Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drugs Targeting SLC Transporters Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhengda Tianqing
  2. 8.1.1 Zhengda Tianqing Company Information
  3. 8.1.2 Zhengda Tianqing Business Overview
  4. 8.1.3 Zhengda Tianqing Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhengda Tianqing Drugs Targeting SLC Transporters Product Portfolio
  6. 8.1.5 Zhengda Tianqing Recent Developments
  7. 8.2 Janssen Pharmaceuticals
  8. 8.2.1 Janssen Pharmaceuticals Company Information
  9. 8.2.2 Janssen Pharmaceuticals Business Overview
  10. 8.2.3 Janssen Pharmaceuticals Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Janssen Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio
  12. 8.2.5 Janssen Pharmaceuticals Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Drugs Targeting SLC Transporters Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Drugs Targeting SLC Transporters Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Drugs Targeting SLC Transporters Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Kelun Pharmaceutical
  32. 8.6.1 Kelun Pharmaceutical Company Information
  33. 8.6.2 Kelun Pharmaceutical Business Overview
  34. 8.6.3 Kelun Pharmaceutical Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kelun Pharmaceutical Drugs Targeting SLC Transporters Product Portfolio
  36. 8.6.5 Kelun Pharmaceutical Recent Developments
  37. 8.7 Bristol-Myers Squibb
  38. 8.7.1 Bristol-Myers Squibb Company Information
  39. 8.7.2 Bristol-Myers Squibb Business Overview
  40. 8.7.3 Bristol-Myers Squibb Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bristol-Myers Squibb Drugs Targeting SLC Transporters Product Portfolio
  42. 8.7.5 Bristol-Myers Squibb Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Drugs Targeting SLC Transporters Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Starpharma
  50. 8.9.1 Starpharma Company Information
  51. 8.9.2 Starpharma Business Overview
  52. 8.9.3 Starpharma Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Starpharma Drugs Targeting SLC Transporters Product Portfolio
  54. 8.9.5 Starpharma Recent Developments
  55. 8.10 Orifarm
  56. 8.10.1 Orifarm Company Information
  57. 8.10.2 Orifarm Business Overview
  58. 8.10.3 Orifarm Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Orifarm Drugs Targeting SLC Transporters Product Portfolio
  60. 8.10.5 Orifarm Recent Developments
  61. 8.11 Jnana Therapeutics
  62. 8.11.1 Jnana Therapeutics Company Information
  63. 8.11.2 Jnana Therapeutics Business Overview
  64. 8.11.3 Jnana Therapeutics Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jnana Therapeutics Drugs Targeting SLC Transporters Product Portfolio
  66. 8.11.5 Jnana Therapeutics Recent Developments
  67. 8.12 Hengrui
  68. 8.12.1 Hengrui Company Information
  69. 8.12.2 Hengrui Business Overview
  70. 8.12.3 Hengrui Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hengrui Drugs Targeting SLC Transporters Product Portfolio
  72. 8.12.5 Hengrui Recent Developments
  73. 8.13 Hansoh Pharmaceuticals
  74. 8.13.1 Hansoh Pharmaceuticals Company Information
  75. 8.13.2 Hansoh Pharmaceuticals Business Overview
  76. 8.13.3 Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hansoh Pharmaceuticals Drugs Targeting SLC Transporters Product Portfolio
  78. 8.13.5 Hansoh Pharmaceuticals Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Drugs Targeting SLC Transporters Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Drugs Targeting SLC Transporters Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drugs Targeting SLC Transporters Value Chain Analysis
  2. 9.1.1 Drugs Targeting SLC Transporters Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drugs Targeting SLC Transporters Production Mode & Process
  6. 9.2 Drugs Targeting SLC Transporters Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drugs Targeting SLC Transporters Distributors
  9. 9.2.3 Drugs Targeting SLC Transporters Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst